{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:00:23Z","timestamp":1790362823291,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rosacea is a chronic inflammatory skin disease that is characterized by recurrent episodes of erythema, telangiectasia and papulopustular lesions. Although the pathogenesis is not well established, growing knowledge suggests that multiple etiological factors play a role resulting in inflammation. The aim of the present study is to investigate inflammatory status of patients with rosacea by evaluating CBC parameters and systemic immune inflammation (SII) index and compare these parameters with control group. Thus, it is aimed to understand the role of systemic inflammation in the pathogenesis of the disease. This retrospective, case\u2013control study included 100 patients with rosacea and 58 sex- and age-matched controls. Laboratory examinations including CBC, ESR, CRP, HDL, LDL, and triglyceride levels were recorded and neutrophil\u2013lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MLR), and platelet-lymphocyte ratio (PLR), monocyte-to-high-density lipoprotein ratio (MHR) and SII index were calculated. Monocyte and platelet count, SII index, ESR and CRP were significantly higher in patients with rosacea than in the control group. No statistically significant difference was found in other parameters. There was no significant correlation between disease severity and ESR, CRP, and SII index. The findings of this study suggest that apart from the inflammatory pathways at the level of skin, there is an inflammatory state in the blood of patients. Rosacea is a skin disease, but it may have systemic implications and\/or associations that need to be clarified completely.<\/jats:p>","DOI":"10.1038\/s41598-023-36247-5","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T06:04:11Z","timestamp":1685945051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of inflammatory status in blood in patients with rosacea"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-1628","authenticated-orcid":false,"given":"Nermin","family":"Karaosmanoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5286-3260","authenticated-orcid":false,"given":"P\u0131nar","family":"Ozdemir Cetinkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-7323","authenticated-orcid":false,"given":"Ozge Mine","family":"Orenay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"36247_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","volume":"78","author":"RL Gallo","year":"2018","unstructured":"Gallo, R. L. et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J. Am. Acad. Dermatol. 78, 148\u2013155 (2018).","journal-title":"J. Am. Acad. Dermatol."},{"key":"36247_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40257-021-00595-7","volume":"22","author":"EJ van Zuuren","year":"2021","unstructured":"van Zuuren, E. J. et al. Rosacea: New concepts in classification and treatment. Am. J. Clin. Dermatol. 22, 457\u2013465 (2021).","journal-title":"Am. J. Clin. Dermatol."},{"key":"36247_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","volume":"15","author":"VD Schwab","year":"2011","unstructured":"Schwab, V. D. et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J. Investig. Dermatol. Symp. Proc. 15, 53\u201362 (2011).","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"36247_CR4","doi-asserted-by":"crossref","unstructured":"Woo, Y.R., Lim, J.H., Cho, D.H. & Park, H.J. Rosacea: Molecular mechanisms and management of a chronic cutaneous inflammatory condition. Int. J. Mol. Sci. 17(2016).","DOI":"10.3390\/ijms17091562"},{"key":"36247_CR5","doi-asserted-by":"crossref","unstructured":"Buddenkotte, J. & Steinhoff, M. Recent advances in understanding and managing rosacea. F1000Res 7(2018).","DOI":"10.12688\/f1000research.16537.1"},{"key":"36247_CR6","doi-asserted-by":"crossref","unstructured":"Rainer, B.M., Fischer, A.H., Luz Felipe da Silva, D., Kang, S. & Chien, A.L. Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study. J. Am. Acad. Dermatol. 73, 604\u2013608 (2015).","DOI":"10.1016\/j.jaad.2015.07.009"},{"key":"36247_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.det.2017.11.006","volume":"36","author":"N Vera","year":"2018","unstructured":"Vera, N., Patel, N. U. & Seminario-Vidal, L. Rosacea comorbidities. Dermatol. Clin. 36, 115\u2013122 (2018).","journal-title":"Dermatol. Clin."},{"key":"36247_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jaad.2017.07.055","volume":"78","author":"AD Holmes","year":"2018","unstructured":"Holmes, A. D., Spoendlin, J., Chien, A. L., Baldwin, H. & Chang, A. L. S. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J. Am. Acad. Dermatol. 78, 156\u2013166 (2018).","journal-title":"J. Am. Acad. Dermatol."},{"key":"36247_CR9","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1111\/jocd.13254","volume":"19","author":"N Altunisik","year":"2020","unstructured":"Altunisik, N., Turkmen, D. & Sener, S. Investigation of the relationship between inflammatory blood parameters and rosacea and demodex infestation. J. Cosmet. Dermatol. 19, 2105\u20132108 (2020).","journal-title":"J. Cosmet. Dermatol."},{"key":"36247_CR10","unstructured":"Akin Belli, A., Kara, A. & Ozbas Gok, S. Can hematologic parameters be an indicator of metabolic disorders accompanying rosacea? Acta Dermatol. Croat. 25, 145\u2013150 (2017)."},{"key":"36247_CR11","doi-asserted-by":"crossref","unstructured":"Karaosmanoglu, N., Karaaslan, E. & Ozdemir Cetinkaya, P. Evaluation of serum uric acid levels in patients with rosacea. Arch. Dermatol. Res. 312, 447\u2013451 (2020).","DOI":"10.1007\/s00403-020-02033-w"},{"key":"36247_CR12","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/jocd.13395","volume":"19","author":"D Turkmen","year":"2020","unstructured":"Turkmen, D. Serum bilirubin and uric acid antioxidant levels in rosacea patients. J. Cosmet. Dermatol. 19, 2717\u20132720 (2020).","journal-title":"J. Cosmet. Dermatol."},{"key":"36247_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jaad.2004.01.048","volume":"50","author":"J Wilkin","year":"2004","unstructured":"Wilkin, J. et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J. Am. Acad. Dermatol. 50, 907\u2013912 (2004).","journal-title":"J. Am. Acad. Dermatol."},{"key":"36247_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/jid.2010.351","volume":"131","author":"K Yamasaki","year":"2011","unstructured":"Yamasaki, K. et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J. Invest. Dermatol. 131, 688\u2013697 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"36247_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105238","volume":"9","author":"HL Kelhala","year":"2014","unstructured":"Kelhala, H. L. et al. IL-17\/Th17 pathway is activated in acne lesions. PLoS ONE 9, e105238 (2014).","journal-title":"PLoS ONE"},{"key":"36247_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ds.ds_28_22","volume":"40","author":"YC Weng","year":"2022","unstructured":"Weng, Y. C. Skin microbiome in acne vulgaris, skin aging, and rosacea: An evidence-based review. Dermatol. Sin. 40, 129\u2013142 (2022).","journal-title":"Dermatol. Sin."},{"key":"36247_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4103\/ds.ds_3_20","volume":"38","author":"KAM Yilmaz","year":"2020","unstructured":"Yilmaz, K. A. M., Dikicier, B. S., Y\u00fcksekal, G. & K\u00f6roglu, M. Is there a relationship between rosacea with gut dysbiosis?. Dermatol. Sin. 38, 88\u201393 (2020).","journal-title":"Dermatol. Sin."},{"key":"36247_CR18","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu, B. et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin. Cancer Res. 20, 6212\u20136222 (2014).","journal-title":"Clin. Cancer Res."},{"key":"36247_CR19","first-page":"352","volume":"46","author":"A Yorulmaz","year":"2020","unstructured":"Yorulmaz, A., Hayran, Y., Akpinar, U. & Yalcin, B. systemic immune-inflammation index (SII) Predicts increased severity in psoriasis and psoriatic arthritis. Curr. Health Sci. J. 46, 352\u2013357 (2020).","journal-title":"Curr. Health Sci. J."},{"key":"36247_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14101","volume":"75","author":"D Dincer Rota","year":"2021","unstructured":"Dincer Rota, D. & Tanacan, E. The utility of systemic-immune inflammation index for predicting the disease activation in patients with psoriasis. Int. J. Clin. Pract. 75, e14101 (2021).","journal-title":"Int. J. Clin. Pract."},{"key":"36247_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/ced.14432","volume":"46","author":"E Tanacan","year":"2021","unstructured":"Tanacan, E., Dincer, D., Erdogan, F. G. & Gurler, A. A cutoff value for the systemic immune-inflammation index in determining activity of Behcet disease. Clin. Exp. Dermatol. 46, 286\u2013291 (2021).","journal-title":"Clin. Exp. Dermatol."},{"key":"36247_CR22","first-page":"63","volume":"48","author":"C Turan","year":"2022","unstructured":"Turan, C. & Metin, N. A Novel Inflammatory Marker in the Follow-up of Moderate-to-Severe Acne Vulgaris Administered Isotretinoin: Systemic Immune-Inflammation Index (SII). Curr. Health Sci. J. 48, 63\u201367 (2022).","journal-title":"Curr. Health Sci. J."},{"key":"36247_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14835","volume":"34","author":"T Cetinarslan","year":"2021","unstructured":"Cetinarslan, T., Turel Ermertcan, A., Ozyurt, B. & Gunduz, K. Evaluation of the laboratory parameters in hidradenitis suppurativa: Can we use new inflammatory biomarkers?. Dermatol. Ther. 34, e14835 (2021).","journal-title":"Dermatol. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36247-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T06:12:00Z","timestamp":1685945520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36247-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36247"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-36247-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9068"}}